Status:
UNKNOWN
Postpolypectomy Bleeding in Patients With Antiplatelet Therapy
Lead Sponsor:
Soonchunhyang University Hospital
Conditions:
Bleeding Complication During Colon Polypectomy
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine if the use of aspirin prior to colonoscopy increases the risk of post polypectomy bleeding. The primary end point is comparison of bleeding rates after polype...
Detailed Description
Based on very limited evidences, ASGE recommended that endoscopic procedures may be performed on patients taking aspirin. However in a survey of ASGE members regarding their endoscopic practice, 81% w...
Eligibility Criteria
Inclusion
- The patients who take low dose aspirin (75\~160mg) for primary prevention of vascular disease and low risk for thromboembolism.
Exclusion
- The patients who taking anti-thrombotic agents,
- The patients who taking thienopyridines or other NSAID with aspirin,
- The patients who have low platelet count(\<80,000/mm3) and prolongated PT/aPTT in laboratory test,
- The patients who have chronic renal disease (creatinine\>3mg/dl over 6 months),
- The patients who have polyps over than 1 cm in size or thick pedicle over 1 cm,
- The patients who have GI malignancies,the patients who are over ASA classification class III.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01465256
Start Date
April 1 2012
End Date
June 1 2014
Last Update
March 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soonchunhyang univerisity hospital
Seoul, Seoul, South Korea, 140-743